Tiziana Life Sciences
Tiziana Life Sciences is developing its monoclonal antibody named TZLS-501 for the treatment of COVID-19.
Rankings by
National Ranking50th
in United Kingdom Regional Ranking265th
in Western Europe Global Ranking1146th
worldwide